Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/25 mg is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is Olmesartan Medoxomil; Amlodipine; Hydrochlorothiazide.
Product ID | 13668-385_7b2f628e-b066-47f3-b5da-d6987ef76a29 |
NDC | 13668-385 |
Product Type | Human Prescription Drug |
Proprietary Name | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/25 mg |
Generic Name | Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Tablet 40/5/25 Mg |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2016-10-26 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA203580 |
Labeler Name | TORRENT PHARMACEUTICALS LIMITED |
Substance Name | OLMESARTAN MEDOXOMIL; AMLODIPINE; HYDROCHLOROTHIAZIDE |
Active Ingredient Strength | 40 mg/1; mg/1; mg/1 |
Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |